China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
Release time：2024-04-30 08:15:46 Source：Cultural Carousel news portal
-
Contact Us
- Home
- News
- People
- In-depth
- ACWF
- 2023 Women Science and Technology Innovation Pioneer...
- People Enjoy Blooming Tulips in Jinan, East...
- Flowers Bloom Across China in Spring
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
September 1, 2022 |
| A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Comments
Magazines
Projects
Photos
Special Coverage
- Previous：Chinese enterprises keen to expand int'l market: Trade council
- Next：3 dead, 4 missing in explosion at Italy power station
Related articles
- Immersive Studio Ghibli exhibition opens in Shanghai
- A job with Fred the Shred, selling milk to the Chinese
- From deep sadness to dazzling pomp, 15 key revelations from the must
- WorkSafe interim chief executive Steve Haszard resigns months into job
- Chinese ballet to illuminate Dutch stadium
- US House passes controversial surveillance bill on 4th attempt
- Princess Beatrice and Edoardo Mapelli Mozzi are all smiles as they join his mother
- Al Cowlings
- The North London neighbourhood plagued by anti
- King Charles's call for all able
- Syrian, Russian forces destroy 'terrorist' strongholds in N. Syria
- US, UK intelligence leaders raise fresh alarms about Chinese espionage
- Kings and royal princes were the rock stars of their day
- Queen Letizia and King Felipe arrive at funeral of Fernando Gomez
- Williamson to lead New Zealand at the Twenty20 World Cup; Southee to make his 7th appearance
- How Katharine, Duchess of Kent bagged a royal prince
- New US inflation data 'along the lines' of what Fed wants, Powell says
- JAN MOIR: Why JK Rowling SHOULDN'T forgive the weaselly band
- 1 dead, 7 missing after 2 Japan MSDF helicopters crash near Izu Islands
- Lady Tatiana Mountbatten
Random recommendation
- Copyright © 2024 Powered by China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial ,Cultural Carousel news portal sitemap